Home / Drug shortages / Sodium Chloride 0.9% Injection

Sodium Chloride 0.9% Injection — FDA Drug Shortage

To Be Discontinued — Hospira, Inc., a Pfizer Company

The FDA lists a drug shortage record for Sodium Chloride 0.9% Injection (injection) from Hospira, Inc., a Pfizer Company with status To Be Discontinued. The shortage was first posted on 12/03/2025.

Shortage Details

Status
To Be Discontinued
Company
Hospira, Inc., a Pfizer Company
Package NDC
0409-7101-02
Dosage Form
Injection
Presentation
Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02)
Initial Posting
12/03/2025
Revised Date

FDA data resources